Omnicell, Inc. (OMCL): Price and Financial Metrics

OMCL Stock Price Chart Interactive Chart >

OMCL Price/Volume Stats

Omnicell, Inc. (OMCL) Company Bio

Omnicell provides automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. The company was founded in 1992 and is based in Mountain View, California.

OMCL Price Forecast Based on DCF Valuation

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for OMNICELL Inc. To summarize, we found that OMNICELL Inc ranked in the 40th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 45%. In terms of the factors that were most noteworthy in this DCF analysis for OMCL, they are:

• The compound growth rate in the free cash flow of OMNICELL Inc over the past 5.56 years is 0.3%; that's better than 64.5% of cash flow producing equities in the Technology sector, where it is classified.
• The business' balance sheet suggests that 8% of the company's capital is sourced from debt; this is greater than only 24.57% of the free cash flow producing stocks we're observing.
• OMNICELL Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as OMCL, try MSI, TDY, BKTI, CSCO, and FORM.